3 results match your criteria: "Yale University Department of Internal Medicine[Affiliation]"
Polysomnographic predictors of incident diabetes and pre-diabetes: an analysis of the DREAM study.
J Clin Sleep Med
April 2023
Yale University Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, New Haven, Connecticut.
Study Objectives: We sought to evaluate sleep measures that better predict incident diabetes and prediabetes in a large cohort of veterans.
Methods: This secondary analysis included 650 patients without baseline diabetes from a multisite observational veterans' cohort. Participants underwent obstructive sleep apnea evaluation via laboratory-based polysomnography between 2000 and 2004 with follow-up through 2012.
infection identified on urine microscopy.
BMJ Case Rep
April 2022
Section of Nephrology, Yale University Department of Internal Medicine, New Haven, Connecticut, USA.
Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support.
Respir Med Case Rep
March 2021
Yale University Department of Internal Medicine, New Haven, CT, 06513, USA.
It has been postulated that the underlying pathophysiology of COVID-19 is mediated by cytokine storm resulting in a hyperinflammatory state. A similar kind of cytokine-storm has been described in individuals undergoing veno-venous extracorporeal membrane oxygenation (VV ECMO) support. There is therefore concern that initiation of VV ECMO support among COVID19 patients could further exacerbate this dysregulated inflammatory response.
View Article and Find Full Text PDF